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What is known about the subject?
 ► COVID-19 has been described globally in children 
and adults of all age groups.
 ► Few cases have been reported in neonates and 
preterm babies.
What this study adds?
 ► This review found only 10 published cases of 
COVID-19 in neonates, as well as reporting a further 
case.
 ► The course appears mild and vertical transmission 
even rarer, occurring in only three cases.
AbstrACt
Objective To carry out a systematic review of the 
available studies on COVID-19 (coronavirus disease 2019) 
in neonates seen globally since the onset of the COVID-19 
global pandemic in 2020. The paper also describes a 
premature baby with reverse transcription (RT)- PCR- 
positive COVID-19 seen at the Blackpool Teaching 
Hospitals NHS Foundation Trust, UK.
Design We conducted a multifaceted search of the 
Cumulative Index to Nursing and Allied Health Literature, 
Embase, Medline and PubMed from 1 December 2019 to 
12 May 2020 to harvest articles from medical journals and 
publications reporting cases of COVID-19 in neonates from 
anywhere in the world. Additional searches were also done 
so as not to miss any important publications. Write- up was 
in line with the Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses, the protocol for the review 
was registered with International Prospective Register of 
Systematic Reviews (PROSPERO), and risk of bias was 
analysed with the Newcastle- Ottawa tool. Additionally, the 
preterm neonate with COVID-19 from our hospital is also 
reported.
results The systematic review has revealed eight 
studies where neonates have been described to have 
confirmed COVID-19, with low risk of bias. Of the 10 
reported cases elsewhere, only three are likely to be 
vertically transmitted, while seven occurred in the 
postperinatal period and are likely to have been postnatally 
acquired. All neonates had a mild course, recovered fully 
and were negative on retesting. Our case of COVID-19 in 
a 32- week premature baby from the UK was delivered by 
emergency caesarean section, with the mother wearing 
a face mask and the family having no contact with the 
neonate, suggesting vertical transmission. On day 33, the 
neonate was asymptomatic but was still RT- PCR- positive 
on nasopharyngeal airway swab.
Conclusions Neonatal infection is uncommon, with 
only two previously reported cases likely to be of vertical 
transmission. The case we report is still RT- PCR- positive 
on day 28 and is asymptomatic. Ongoing research is 
needed to ascertain the epidemiology of COVID-19 in 
neonates.
IntrODuCtIOn
The novel coronavirus disease (COVID-
19) is a highly contagious disease that was 
first reported in Wuhan, Hubei Province, 
China in December 2019. Within weeks of 
the emergence of the disease, it has spread 
to several countries, and the WHO declared 
the outbreak as a public health emergency of 
international concern in January 2020 and as 
a pandemic in March 2020.1 According to the 
WHO’s Situation Report 113 published on 12 
May 2020, coronavirus now affects 210 coun-
tries and 2 international conveyances, and 
has affected more than 4 100 000 persons, 
with more than 283 000 individuals dead.2
COVID-19 is caused by severe acute respi-
ratory syndrome coronavirus 2 (SARS- CoV-2), 
previously known as the 2019 novel corona-
virus or 2019- nCoV. SARS- CoV-2 is a novel 
member of coronaviruses, which are a large 
class of highly diverse, enveloped, positive- 
sense, single- stranded RNA viruses.3 Most 
reported cases of the disease are in adults, 
but the disease has also been reported in chil-
dren, including neonates.4
While COVID-19 typically presents as acute 
respiratory disease and pneumonia, it has 
been reported to also impact other systems 
including the gastrointestinal tract.5 The 
first reported paediatric case of COVID-19 
was probably of a 10- year- old boy from Shen-
zhen, China diagnosed with the condition in 
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Table 1 Risk of bias assessment of the included studies (case reports and case series)
Study Cases (n) Question 1 Question 2 Question 3 Question 4 Question 5 Risk of bias
Alzamora et al29 1 Yes Yes Yes Yes Yes Low
Kamali Aghdam et al30 1 Yes Yes Yes Yes Yes Low
Chacón- Aguilar et al31 1 Yes Yes Yes Yes Yes Low
Piersigilli et al32 1 Yes Yes Yes Yes Yes Low
Wang et al33 1 Yes Yes Yes Yes Yes Low
Wang et al34 1 Yes Yes Yes Yes Yes Low
Yu et al35 1 Yes Yes Yes Yes Yes Low
Zeng et al36 3 Yes Yes Yes Yes Yes Low
Tool details
Low risk items: Green shading, Unclear risk: Yellow shading, High risk: red shading
January 2020.6 Since then, there have been a few other 
reports of confirmed COVID-19 in neonates.
We did a rapid systematic review to summarise the 
published data on neonatal presentations of COVID-19. 
We also report a case of a 32- week premature baby with 
COVID-19 born to a COVID-19- affected mother.
MethODs
search strategy and study selection
This study is reported in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses.7 The protocol was registered with the Interna-
tional Prospective Register of Systematic Reviews (PROS-
PERO).8 Considering the date of the earliest confirmed 
reports of COVID-19, we have searched PubMed, 
Medline, Embase and Cumulative Index to Nursing and 
Allied Health Literature for studies published since 1 
December 2019. The WHO database of publications on 
novel coronavirus was additionally searched for poten-
tially relevant publications.9 We also searched the refer-
ences listed within the retrieved articles to try and iden-
tify additional citations that may have been missed during 
the electronic search.
Eligible studies (including case reports, case series, 
cohort studies and retrospective studies) published 
in English- language peer- reviewed journals that have 
described original demographic and clinical characteris-
tics of children diagnosed with COVID-19 were included 
for analysis. Review articles and opinion articles not 
reporting original data were excluded.
For the purpose of the electronic search, studies 
were identified with the following search terms: (coro-
navirus OR covid19 OR COVID-19 OR SARS- Cov-2 OR 
2019- nCoV) AND (neonat* OR infant OR preterm OR 
premature OR Prem) AND (case report OR case series 
OR symptom OR symptoms OR characteristics OR char-
acteristic*). We included both medical subject headings 
and free- text terms.
Two independent reviewers (MG and TK) evaluated 
the titles and abstracts of papers to identify relevant 
studies. Articles identified were then independently 
assessed by the two reviewers using predefined eligibility 
criteria. Any disagreements between authors regarding 
study inclusion were resolved through discussion among 
the reviewers.
risk of bias
For cohort and case–control studies, we used the Newcastle- 
Ottawa tool10 to assess the risk of bias. For case reports and 
case series, we used the tool suggested by Murad et al.11 This 
had previously been used in published systematic reviews,12 
and was adapted from the Newcastle- Ottawa tool by the 
removal of items that relate to comparability and adjust-
ment (which are not relevant to non- comparative studies) 
and retained items that focused on selection, represent-
ativeness of cases, and ascertainment of outcomes and 
exposure. This resulted in five criteria in the form of ques-
tions with a binary response (yes/no), whether the item 
was suggestive of bias or not. We considered the quality of 
the report as good (low risk of bias) when all five criteria 
were fulfilled, moderate when four were fulfilled, and poor 
(high risk of bias) when three or fewer were fulfilled. In the 
end, all the eight selected studies had a low risk of bias and 
were deemed good (table 1).
Data extraction
Data were extracted independently by the two reviewers 
on to a Microsoft Excel spreadsheet using a predefined 
checklist. Extracted data included but were not limited to 
the following: study design, year of publication, country, 
author name(s), number of patients, patient demo-
graphics, gastrointestinal symptoms and/or signs, other 
clinical symptoms and timing of gastrointestinal symp-
toms in relation to respiratory symptoms. The extracted 
data were compared and differences were discussed and 
resolved by consensus.
statistical analysis
Statistical analyses were mainly descriptive (numer-
ical and graphical). Frequencies and proportions were 
used to summarise qualitative variables, whereas means, 
medians, SD and quartiles or ranges were used to summa-
rise quantitative variables. Where possible, meta- analyses 
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Figure 1 Flow diagram for study selection.
using the random- effects model were performed to assess 
associations between demographic features and gastroin-
testinal symptoms. All statistical analyses were performed 
using StatsDirect statistical software.
Case report
The research and development department approved 
the writing of this paper.
Patient and public involvement
Patients and/or the public were not involved in the 
design, or conduct, or reporting, or dissemination plans 
of this research.
results
Our search was performed on 12 May 2020, and initial 
screening yielded 27 publications for full- text searching 
when screened against the inclusion and exclusion 
criteria. One of these publications was unrelated to 
neonates and was excluded.13 Ten other publications 
were excluded as the neonate(s) in all these were not 
confirmed to be infected.14–24 It is worth noting that one 
of the cases24 reported a COVID-19- positive mother who 
was very unwell and delivered by caesarean section at the 
bedside; the 35- week neonate unfortunately died within 
2 hours. No further details regarding the neonate are 
described and confirmation of diagnosis is not reported; 
hence, this case was excluded.
Four other publications were excluded as these were 
review articles (figure 1).25–28
This left eight articles that described neonates with 
COVID-19 confirmed on reverse transcription (RT)- 
PCR swabs. The characteristics of the included studies 
are shown in table 2. They included descriptions of one 
neonate each from Peru,29 Iran,30 Spain31 and Belgium32 
and six from China.33–36
The clinical characteristics of the 10 babies described 
in the eight publications are listed in table 2.
The report from Peru29 describes the occurrence of 
COVID-19 in a presumed 34- week baby who tested posi-
tive as early as 16 hours of life. The baby was intubated 
on day 0 and needed respiratory support for 6 days, 
but made an uneventful recovery therefrom. Imaging 
was negative. The baby had been separated from the 
mother at birth and had no postnatal contact with the 
family or anyone who was coronavirus- positive. This 
may be a case of vertical transmission.
The Iranian case report30 describes the occurrence of 
COVID-19 in a 15- day- old neonate. Details regarding the 
neonate’s delivery records are sketchy. This is unlikely 
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to be a vertical transmission. Also, the mother did not 
undergo any diagnostic tests.
The report from Spain31 describes a 26- day- old neonate 
presenting to the hospital with two episodes of presumed 
seizures. The baby was treated empirically with antibi-
otics, but tested positive for SARS- CoV-2 on nasopha-
ryngeal swab. The baby was discharged after 6 days, with 
recommendations for home isolation for a further period 
of time. He was clinically well at discharge.
The report from Belgium32 is of a baby delivered at 
26+4 weeks of gestation and discovered to have a posi-
tive nasopharyngeal swab for SARS- CoV-2 RT- PCR done 
on her after her mother tested positive on account of 
ill health on day 7 after preterm delivery by caesarean 
section. The baby’s results turned negative 14 days after 
the initial positive result. She was still on the neonatal 
unit on account of her extreme prematurity.
The four case reports from China are from secondary 
(2) and tertiary (2) hospitals. In the study by Wang et 
al,33 both parents were COVID-19- positive. The baby 
presented with vomiting and diarrhoea on day 17 of 
life and was initially negative up to the 20th day of life, 
but turned positive on day 23, and later negative on day 
29. The baby was discharged 14 days after admission 
and remained well, with no respiratory symptoms and 
needing no treatment.
The case described by Wang et al34 is a presumed 
vertical transmission in a term neonate that tested posi-
tive at 36 hours after birth. Placental and birth products 
tested negative, and the baby and the mother had no 
contact intranatally or postnatally. The baby remained 
asymptomatic and was discharged on day 18 after the 
17th- day swabs tested negative.
The report by Yu et al35 describes a COVID-19- positive 
asymptomatic term neonate born to a positive mother by 
caesarean section. The baby was discharged after 2 weeks’ 
stay in Wuhan Children’s Hospital in Wuhan, China. This 
study reported the outcome in six other positive mothers 
whose babies tested negative.
Finally, Zeng et al36 describe 3 out of 33 neonates in 
their series from the Wuhan Children’s Hospital who 
tested positive on nasopharyngeal swabs for SARS- CoV-2 
by RT- PCR. All the neonates were born by caesarean 
section. In each case, the mother had COVID-19 pneu-
monia. While two babies were born at term, one was born 
preterm. All babies were symptomatic and had positive 
swabs on days 2 and 4 of life, but tested negative on days 
6 (in two babies) and 7 (in the preterm baby).
Case report
A 36- year- old, gravida 3 mother presented at 32 weeks of 
gestational age with cough, high fever, lymphopaenia and 
a positive RT- PCR swab for SARS- CoV-2. She underwent 
an emergency caesarean section after being given two 
doses of antenatal steroids 12 hours apart. The mother 
wore a fluid- resistant mask, and the entire operative team 
was dressed in full personal protective equipment. The 
baby was a live, female newborn weighing 2150 g. She 
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was directly handed over to the neonatal team without 
any contact with the mother. Postnatally, she has had 
no contact with the mother or the father or any family 
member.
She needed respiratory support, increasing from high- 
flow nasal oxygen and then requiring surfactant via less 
invasive surfactant administration, progressing to intu-
bation. The baby was extubated the next day and then 
moved to biphasic positive airway pressure support, 
weaning over the next few days to air.
The radiograph showed findings consistent with surfac-
tant deficiency lung disease. The initial RT- PCR swab on 
day 1 of life was negative, but the child had a positive 
swab on day 4, day 14 and also on day 21, while being 
asymptomatic.
While the baby gradually recovered and is being 
isolated in the neonatal unit and being fed and nursed, 
the mother deteriorated rapidly after the delivery and 
was kept on a ventilator in the intensive care unit of the 
hospital for a week. She underwent tracheostomy. Over 
the past week, she continued to improve, and she has 
now been moved out of the intensive care unit and the 
tracheostomy has been closed. She remains on oxygen at 
the time of writing this paper.
The baby remained RT- PCR- positive on day 28 of 
life, but was clinically well, and was discharged with the 
mother on day 33 of life.
DIsCussIOn
This systematic review of published literature has shown 
only 10 case reports of neonatal COVID-19 infection. 
While seven of these ten babies were full- term, three 
were preterm, the lowest being at 26+4 weeks of gesta-
tion. Three are suspected to be vertically transmitted, 
in addition to our own case, the summary of which has 
been described. Ours is the first case of a premature baby 
with COVID-19 in the UK and the fourth preterm baby 
globally. Also, our baby continued to remain positive at 
28 days of life. It remains to be seen when the baby will 
become RT- PCR- negative, although it is clear that the 
baby is otherwise asymptomatic from the coronavirus 
infection.
Global knowledge about this new infectious pandemic 
is evolving. The current knowledge is that the virus is 
less virulent in children, although there have been case 
reports of older children dying as a result of contracting 
the infection. There is no available proven treatment, 
although many trials on different known and new drugs 
are ongoing both in the UK and elsewhere in the world.
Our rapid review concentrates on neonatal COVID-
19. The methodology was performed rapidly; however, 
this did not impact the high- quality systematic approach 
that such a review requires. We present only 10 positive 
neonatal cases from the global literature within the last 5 
months since the pandemic started to emerge, and only 
three were potentially of vertical transmission. Within 
our excluded studies, it is worth noting that a further 65 
neonates were reported as born to COVID-19- positive 
mothers who themselves tested negative on RT- PCR.14 16–22 
As the goal of the review was not to report well neonates 
born to infected mothers, this is likely a small represen-
tation of a much larger sample of reported cases of well 
neonates. Therefore, it does currently seem reasonable 
to suggest that vertical transmission to neonates and 
neonatal infection from infected family members are 
both rare occurrences. Additionally, when they do occur, 
the course appears mild. A previous review which was 
performed up to March 2020 considered children and 
neonates and found a similar mild course within these 
cohorts.37
The main limitation of this review is the relative novelty 
of COVID-19. It is possible that many more cases are 
either not reported to scholarly texts or in the process 
of peer review, and the reader must bear this in mind. 
Therefore, it is likely this review will be rapidly out of 
date and a repeat review will be required. Similarly, the 
scope of the review was very precise, and therefore it is 
inappropriate to suggest any firm conclusions regarding 
the incidence of COVID-19- negative neonatal cases born 
to infected mothers or the details of maternal outcomes, 
which would both have to be specific outcomes and are 
better covered in works focused on these issues, some of 
which were uncovered in this review.23 25
We believe that many other reports of this kind will 
emerge. It is key that future research considers the 
possibility of transmission from asymptomatic mothers. 
This will likely become of greater interest as population 
testing increases. It is also of particular interest that the 
case we report has remained RT- PCR- positive on day 28 
and on discharge, despite being asymptomatic. Ques-
tions as to the time needed for seroconversion in infected 
children, the ability to spread while being asymptomatic 
and ongoing immunity after infection all require future 
investigation.
COnClusIOns
Neonatal infection has only been reported in 10 cases, 
with this study adding a case report of an eleventh case. 
Three occurred in the late neonatal period and three were 
presumed cases of vertical transmission, with the addition 
of the case we report likely to be of vertical transmission. 
All 10 previously reported cases had a mild course, and 
respiratory symptoms were generally consistent with their 
gestational age. Ongoing research is needed to ascertain 
the epidemiology of COVID-19 in neonates.
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